Friday, September 18, 2026

Preventive Cardiology · Imaging · Access

Beyond the Tertiary Center: Bringing Coronary Atherosclerosis Detection to Rural Patients

Community CT scanners, opportunistic calcium reads, the PREVENT equations, and remote cardiology consultation can move detection upstream for patients who live far from a heart center.

Cardiology blog · September 18, 2026 · Audience: cardiologists and primary care physicians · Reading time ≈ 9 min

The burden sits where the specialists are not

The 2026 AHA Heart Disease and Stroke Statistics update counts 915,973 US cardiovascular deaths in 2023, more than cancer and accidents combined.

The same report estimates that about 47% of US adults have hypertension, roughly 29.5 million have diagnosed diabetes, and close to 90% have some degree of cardiovascular-kidney-metabolic (CKM) syndrome.

A JACC county-level workforce analysis found no practicing cardiologist in 46.3% of US counties, a gap that covers 86.2% of rural counties and about 22 million residents.

Patients in those counties faced an average 87.1-mile round trip to the nearest cardiologist, compared with 16.3 miles elsewhere, and the mismatch between disease burden and specialist supply was largest in the South.

A separate JACC analysis of 2010–2022 mortality showed age-adjusted cardiovascular death rates rising in rural counties while falling in urban ones, with the widening driven mostly by adults aged 25 to 64.

Age-adjusted cardiovascular mortality, rural versus urban counties, 2010 and 2022 Rural counties rose from 431.6 to 435.0 deaths per 100,000; urban counties fell from 369.3 to 345.5 per 100,000. Age-adjusted CV deaths per 100,000 Rural Urban faded bar = 2010 · solid bar = 2022 0 100 200 300 400 500 Rural · 2010 431.6 Rural · 2022 435.0 Urban · 2010 369.3 Urban · 2022 345.5 2022 rural-vs-urban relative risk 1.53; 1.25 after adjustment for poverty, education, and uninsurance.
Visual 1. Rural cardiovascular mortality edged up between 2010 and 2022 while urban mortality declined; bar lengths are drawn to scale from the reported rates. Original graphic based on the JACC analysis reported by TCTMD.
Table 1. The rural access gap in numbers
MeasureRural / underservedComparison
Counties without a practicing cardiologist86.2% of rural counties46.3% of all US counties
Round-trip distance to nearest cardiologist87.1 miles16.3 miles
Age-adjusted CV mortality, 2022 (per 100,000)435.0345.5 (urban)
Safety-net hospitals offering CCTA22% (rural)57% (urban)
Safety-net hospitals offering CCTA, by size7.7% (6–49 beds)88.9% (400+ beds)

Why the default pathway misses the asymptomatic rural patient

Functional stress testing remains the reflexive first test in many practices, yet it is ordered only after symptoms or suspicion appear and is built to detect flow-limiting stenosis rather than early plaque.

For a patient who lives an hour or more from the nearest stress lab, the fasting, medication holds, multi-hour imaging protocols, and occasional driving restrictions translate into a lost workday and a ride that must be arranged.

The coronary artery calcium (CAC) score is the closest thing to a direct screen for subclinical atherosclerosis, but Original Medicare does not cover it, so most patients pay roughly $100 to $150 out of pocket when they can find a scanner.

Coronary CT itself is thin on the ground outside large centers, as a survey of 391 safety-net hospitals found CCTA available at only 22% of rural facilities versus 57% of urban ones.

What rural adults most often receive instead is a lipid panel and a blood pressure check, which identify risk factors but cannot show whether plaque is already present.

Anatomy-first evidence is now long-term

The SCOT-HEART 10-year follow-up showed that adding CCTA to standard care in stable chest pain lowered coronary death or nonfatal MI from 8.2% to 6.6% (HR 0.79; 95% CI 0.63–0.99).

Nonfatal MI alone fell from 6.0% to 4.3% (HR 0.72), and the benefit tracked with greater use of preventive therapy, mainly statins, in the CT arm (56% vs 49%).

The mechanism matters for rural care, because the dividend of CT came from seeing non-obstructive plaque and treating it, which is work a primary care clinician can carry out locally once the anatomy is known.

The 2021 AHA/ACC chest pain guideline already gives CCTA a Class 1 role in intermediate-risk stable and acute chest pain, so the evidence base for an anatomy-first strategy is not the barrier.

Four tools that travel

1. PREVENT at the primary care visit

The 2026 ACC/AHA dyslipidemia guideline, released March 13, 2026, replaces the pooled cohort equations with the AHA PREVENT equations for adults aged 30 to 79 without known ASCVD.

PREVENT runs on data every rural clinic already collects, including lipids, systolic blood pressure, eGFR, diabetes status, smoking, and treatment history, and it returns both 10-year and 30-year estimates.

The guideline sorts 10-year PREVENT-ASCVD risk into low (<3%), borderline (3% to <5%), intermediate (5% to <10%), and high (≥10%) tiers, with LDL-C goals of <100 mg/dL for borderline or intermediate risk and <70 mg/dL for high risk.

It also recommends a one-time lipoprotein(a) measurement in adulthood, a cheap blood test that flags inherited risk without any imaging.

2. Selective and opportunistic calcium scoring

The guideline's "calculate, personalize, reclassify" model supports CAC in men aged 40 or older and women aged 45 or older at borderline or intermediate risk when the statin decision is uncertain, and any detectable calcium supports an LDL-C goal below 100 mg/dL.

An AHA scientific statement on opportunistic CAC notes that about 19 million noncardiac chest CT scans are performed in the US each year, against roughly 1 million dedicated calcium scans.

Many rural hospitals already run low-dose CT lung cancer screening and trauma or pulmonary CT, so a structured calcium read on scans that already exist costs nothing in travel or radiation.

In the randomized NOTIFY-1 project, simply notifying clinicians and patients about AI-detected incidental calcium raised 6-month statin prescribing to 51.2%, versus 6.9% with usual care.

3. Community-based CCTA with remote reading

A CCTA-capable scanner needs far less capital and staffing than a catheterization laboratory, and the acquisition can be performed by a trained CT technologist while an experienced cardiac CT reader interprets the study from anywhere.

Hospital outpatient payment for CCTA roughly doubled when CMS moved codes 75572–75574 into APC 5572, lifting the technical payment from about $175 in 2024 to $357 in 2025.

That placement continues in 2026 only on a provisional basis, so hospitals are being urged to update their CCTA charges so that cost data support keeping the higher rate.

AI-enabled plaque analysis gained a Category I CPT code (75577) on January 1, 2026, and Heartflow Plaque Analysis now reports coverage from Medicare and four large national commercial payers.

4. Telehealth and eConsults as the specialist bridge

The Consolidated Appropriations Act of 2026 extended Medicare telehealth flexibilities through December 31, 2027, including care delivered to patients at home regardless of rural status or originating site.

In a cluster-randomized cardiology eConsult trial at a community health center, median time to specialist input fell from 24 days to 5 days, and 69% of eConsults were resolved without a face-to-face cardiology visit.

The same trial recorded fewer cardiac emergency department visits in the eConsult arm, which suggests that faster input need not come at the expense of safety.

Table 2. The rural detection toolkit at a glance
ToolWhat it detectsLocal infrastructureWho acts on it2026 coverage / payment note
PREVENT equations10- and 30-year risk (no disease detection)Routine labs and vitalsPrimary carePart of a routine visit
Lipoprotein(a)Inherited risk enhancerStandard labPrimary careOnce per lifetime per guideline
Dedicated CAC scanCalcified plaque burdenAny modern CTPrimary care, with cardiology inputNot covered by Original Medicare; cash price often $100–150
Opportunistic CACCalcium on existing chest CTExisting scans plus reporting protocolRadiology → primary careNo new scan; depends on structured reporting
CCTAStenosis, total plaque, high-risk features≥64-slice CT, trained technologistRemote cardiac CT reader → primary care or cardiologyHospital outpatient APC 5572 (provisional in 2026)
AI plaque analysisQuantified plaque volume and compositionCloud-based software on CCTA dataCardiologyCPT 75577 (from January 2026); Heartflow HTFL, Cleerly (no ticker, private)
eConsult / video visitSpecialist triage of resultsEHR messaging or video linkCardiology ↔ primary careMedicare telehealth flexibilities through December 2027

A hub-and-spoke pathway for primary prevention

Stitched together, these tools let the rural primary care clinic serve as the front door while the cardiologist acts as the remote interpreter and the tertiary center handles only the patients who need a procedure.

Rural detection pathway Primary care calculates PREVENT risk; low risk gets lifestyle care, borderline to intermediate risk gets selective or opportunistic calcium scoring, high risk starts a statin; symptoms at any stage lead to community CCTA with remote reading, followed by local prevention, eConsult with functional testing, or transfer to the hub. Rural primary care visit PREVENT-ASCVD from lipids, BP, eGFR, diabetes, smoking · one-time Lp(a) Low (<3%) Lifestyle care; periodic reassessment 3% to <10% Selective CAC, or read calcium on an existing chest CT High (≥10%) Start statin; LDL-C goal <70 mg/dL CAC = 0 Statin often deferred; weigh risk enhancers CAC > 0 Statin; LDL-C <100 mg/dL, lower goals as CAC rises symptoms at any stage Community CCTA first-line Acquired by a local CT technologist · read remotely by a cardiac CT reader ± AI plaque analysis or CT-FFR · report routed to primary care and cardiology CAD-RADS 0–2 Intensify prevention locally; telehealth follow-up CAD-RADS 3–4A Cardiology eConsult; CT-FFR or functional test; GDMT CAD-RADS 4B–5 Left main or 3-vessel disease, occlusion: refer to hub for angiography
Visual 2. A hub-and-spoke detection pathway combining 2026 ACC/AHA risk tiers, selective or opportunistic CAC, and community CCTA with remote reading; thresholds follow the 2026 dyslipidemia guideline and CAD-RADS 2.0, and local protocols should govern individual decisions. Original graphic.

Paying for the spokes

The CMS Rural Health Transformation Program is distributing $50 billion over federal fiscal years 2026 to 2030, with every state receiving a $100 million baseline plus workload-based funding in the first year.

Its permitted uses explicitly include equipment, digital tools, telehealth systems, workforce training, and regional care networks, which map directly onto scanners, remote reading, and eConsult platforms.

Because states control how the money is distributed, cardiology groups that want to seed a community CT or eConsult program need to engage their state rural health office early.

Therapy that follows detection

The downstream intervention after a positive calcium or CCTA finding is usually an inexpensive generic statin, which keeps the cost of acting on a rural screening result low for patients.

Table 3. First-line statins used after a positive CAC or CCTA result
GenericBrand · manufacturerRole in this pathwayUS retail pricing*
AtorvastatinLipitor · Viatris VTRSModerate- or high-intensity therapy toward the guideline LDL-C goalGeneric from about $7–12 with GoodRx coupons
RosuvastatinCrestor · AstraZeneca AZNHigh-intensity option when greater LDL-C lowering is neededGeneric from about $12 with GoodRx coupons

*Pricing is time-sensitive (checked September 2026) and varies by pharmacy, dose, quantity, plan, and region; confirm on GoodRx or the manufacturer site.

Case scenario (fictional)

A 61-year-old former smoker who farms about 80 miles from the nearest cardiology office has a routine visit at his county clinic, with a total cholesterol of 212 mg/dL, HDL-C of 41 mg/dL, systolic blood pressure of 142 mmHg on one agent, and normal kidney function.

His 10-year PREVENT-ASCVD estimate falls in the intermediate tier, and a lung cancer screening CT performed at the local hospital a year earlier had mentioned "moderate coronary artery calcification" without any follow-up.

The nurse practitioner sends a cardiology eConsult, and the reviewing cardiologist answers within two days that the documented calcium settles the statin question without a dedicated calcium scan.

Atorvastatin 40 mg is started with an LDL-C goal below 100 mg/dL, and his blood pressure regimen is intensified.

Seven months later he reports new exertional chest tightness, and CCTA at the regional hospital 25 minutes away, read remotely, shows 25–49% proximal LAD stenosis with moderate plaque burden (CAD-RADS 2/P2) and no high-risk features.

Management stays local, with statin intensification, antianginal therapy, and a telehealth cardiology follow-up, and no trip to the tertiary center is needed.

Bottom line

Rural cardiovascular mortality is moving the wrong way while nearly nine in ten rural counties have no cardiologist, so detection has to happen where patients already receive care.

PREVENT and a one-time Lp(a) cost nothing beyond a routine visit, opportunistic calcium reads use scans that already exist, and community CCTA with remote interpretation brings the SCOT-HEART prevention dividend to towns without a heart center.

Telehealth flexibilities through 2027, improved CCTA payment, a new plaque-analysis code, and Rural Health Transformation funds make 2026 a practical year to build the spokes, with the cardiologist serving as interpreter and escalation point rather than gatekeeper.

References

  1. ACC/AHA issue updated guideline for managing lipids, cholesterol. American College of Cardiology, March 13, 2026.
  2. What the latest heart disease and stroke numbers mean for your health. American Heart Association News, January 21, 2026.
  3. No practicing cardiologist in nearly half of US counties, despite higher CV, mortality risk. American College of Cardiology, July 2024.
  4. Rural counties bore brunt of worsening CV mortality during pandemic. TCTMD.
  5. Ten-year outcomes of the SCOT-HEART study. Clinician.com (summary of the Lancet report).
  6. Opportunistic detection of coronary artery calcium on non-cardiac chest CT: top things to know. American Heart Association Professional Heart Daily.

Further viewing

Physician education disclaimer: This article is an educational synthesis for healthcare professionals and does not replace the source guidelines, local protocols, payer policies, or individual clinical judgment; the case scenario is fictional.

Financial disclaimer: Company tickers, payment figures, and drug prices are provided for identification and context only, are time-sensitive (checked September 2026), and are not investment or purchasing advice.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.